Efficacy of baricitinib for refractory large-vessel vasculitis
Rheumatology key messageBaricitinib could be an efficient alternative option in refractory large-vessel vasculitis.
Source: Rheumatology - Category: Rheumatology Source Type: research
More News: Rheumatology | Vasculitis